Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $1.3 billion.

  • Core Scientific's Other Non-Current Liabilities rose 3078.58% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 3078.58%. This contributed to the annual value of $1.1 billion for FY2024, which is 100463.08% up from last year.
  • Core Scientific's Other Non-Current Liabilities amounted to $1.3 billion in Q3 2025, which was up 3078.58% from $1.3 billion recorded in Q2 2025.
  • Core Scientific's Other Non-Current Liabilities' 5-year high stood at $1.3 billion during Q3 2025, with a 5-year trough of $11.1 million in Q2 2022.
  • For the 5-year period, Core Scientific's Other Non-Current Liabilities averaged around $525.8 million, with its median value being $327.5 million (2024).
  • Within the past 5 years, the most significant YoY rise in Core Scientific's Other Non-Current Liabilities was 845925.43% (2023), while the steepest drop was 9033.06% (2023).
  • Over the past 5 years, Core Scientific's Other Non-Current Liabilities (Quarter) stood at $18.5 million in 2021, then soared by 5443.75% to $1.0 billion in 2022, then tumbled by 90.33% to $99.3 million in 2023, then surged by 1004.63% to $1.1 billion in 2024, then increased by 21.25% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $421.9 million during Q1 2025.